DRESS syndrome: clinical myths and pearls.
Publication
, Journal Article
Isaacs, M; Cardones, AR; Rahnama-Moghadam, S
Published in: Cutis
November 2018
Drug rash with eosinophilia and systemic symptoms (DRESS syndrome), also known as drug-induced hypersensitivity syndrome, is an uncommon severe systemic hypersensitivity drug reaction. It typically develops 2 to 6 weeks after exposure to a culprit medication and presents with widespread rash, facial edema, systemic symptoms (eg, fever, rigors, hypotension), lymphadenopathy, evidence of visceral organ involvement, and often eosinophilia. The clinical myths and pearls presented here highlight some of the commonly held assumptions regarding DRESS syndrome in an effort to illuminate subtleties of managing patients with this condition.
Duke Scholars
Published In
Cutis
EISSN
2326-6929
Publication Date
November 2018
Volume
102
Issue
5
Start / End Page
322 / 326
Location
United States
Related Subject Headings
- Humans
- Drug Hypersensitivity Syndrome
- Dermatology & Venereal Diseases
Citation
APA
Chicago
ICMJE
MLA
NLM
Isaacs, M., Cardones, A. R., & Rahnama-Moghadam, S. (2018). DRESS syndrome: clinical myths and pearls. Cutis, 102(5), 322–326.
Isaacs, Michael, Adela R. Cardones, and Sahand Rahnama-Moghadam. “DRESS syndrome: clinical myths and pearls.” Cutis 102, no. 5 (November 2018): 322–26.
Isaacs M, Cardones AR, Rahnama-Moghadam S. DRESS syndrome: clinical myths and pearls. Cutis. 2018 Nov;102(5):322–6.
Isaacs, Michael, et al. “DRESS syndrome: clinical myths and pearls.” Cutis, vol. 102, no. 5, Nov. 2018, pp. 322–26.
Isaacs M, Cardones AR, Rahnama-Moghadam S. DRESS syndrome: clinical myths and pearls. Cutis. 2018 Nov;102(5):322–326.
Published In
Cutis
EISSN
2326-6929
Publication Date
November 2018
Volume
102
Issue
5
Start / End Page
322 / 326
Location
United States
Related Subject Headings
- Humans
- Drug Hypersensitivity Syndrome
- Dermatology & Venereal Diseases